| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 152, Issue 9 4255-4261, Copyright © 1994 by American Association of Immunologists
ARTICLES |
G Deniz, SE Christmas, R Brew and PM Johnson
Department of Immunology, University of Liverpool, UK.
CD3- leukocyte clones derived from human decidualized endometrial tissue of first trimester pregnancy have been compared with CD3- PBL clones. Most CD3- decidual granulated leukocyte (DGL) clones were CD16- CD56+, whereas most CD3- PBL clones were CD16+ CD56+. CD3- DGL and PBL clones, whether CD16+ or not, showed MHC-nonrestricted NK cell activity. However, CD3- CD16- DGL clones had low cytotoxic activity against the NK-resistant cell line BSM, whereas CD3- CD16+ DGL and CD3- PBL clones were strongly cytotoxic. Cytolytic activity has also been investigated in respect of target cell HLA-G expression, because this nonpolymorphic class I MHC molecule is expressed selectively by invasive fetal cytotrophoblast. Class I HLA Ag loss cell mutants were killed efficiently by CD3- DGL clones. Expression of transfected HLA-B8 increased their sensitivity to lysis by most CD3- DGL clones, whereas expression of transfected HLA-G commonly led to decreased target cell killing. In addition, the effects of uncloned CD3- DGL on the one-way MLR have been examined. These cells were very poor responders and, unless cultured to induce expression of class II MHC molecules, were also very poor stimulators. When fresh CD3- DGLs were added as third- party cells, either autologous or allogeneic to responder cells, [3H]TdR incorporation was decreased in the MLR. Thus, CD3- DGL clones express MHC-nonrestricted cytolytic activity, notably against HLA- negative cells, but expression of HLA-G offers protection to target cells. In addition, CD3- DGL may function to suppress allogeneic responses.
This article has been cited by other articles:
|
|
 |
|
  G. Deniz, G. Erten, U. C. Kucuksezer, D. Kocacik, C. Karagiannidis, E. Aktas, C. A. Akdis, and M. Akdis Regulatory NK Cells Suppress Antigen-Specific T Cell Responses J. Immunol., January 15, 2008; 180(2): 850 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vacca, G. Pietra, M. Falco, E. Romeo, C. Bottino, F. Bellora, F. Prefumo, E. Fulcheri, P. L. Venturini, M. Costa, et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function Blood, December 15, 2006; 108(13): 4078 - 4085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-m. Yie, R. Xiao, and C. L. Librach Progesterone regulates HLA-G gene expression through a novel progesterone response element Hum. Reprod., October 1, 2006; 21(10): 2538 - 2544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-m. Yie, L.-h. Li, G.-m. Li, R. Xiao, and C. L. Librach Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro Hum. Reprod., January 1, 2006; 21(1): 46 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Kopcow, D. S. J. Allan, X. Chen, B. Rybalov, M. M. Andzelm, B. Ge, and J. L. Strominger Human decidual NK cells form immature activating synapses and are not cytotoxic PNAS, October 25, 2005; 102(43): 15563 - 15568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Bulla, F Fischetti, F Bossi, and F Tedesco Feto-maternal immune interaction at the placental level Lupus, September 1, 2004; 13(9): 625 - 629. [Abstract] [PDF]
|
|
|
|
|
|
A Ragusa, C de Carolis, A dal Lago, D Miriello, G Ruggiero, A Brucato, M P Pisoni, M Muscara, R Merati, L Maccario, et al. Progesterone supplement in pregnancy: an immunologic therapy? Lupus, September 1, 2004; 13(9): 639 - 642. [Abstract] [PDF]
|
|
|
|
 |
|
 L. A. Koopman, H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, et al. Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential J. Exp. Med., October 20, 2003; 198(8): 1201 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Norwitz, D. J. Schust, and S. J. Fisher Implantation and the Survival of Early Pregnancy N. Engl. J. Med., November 8, 2001; 345(19): 1400 - 1408. [Full Text] [PDF]
|
|
|
|
|
|
I. I. Slukvin, D. P. Lunn, D. I. Watkins, and T. G. Golos Placental expression of the nonclassical MHC class I molecule Mamu-AG at implantation in the rhesus monkey PNAS, August 1, 2000; 97(16): 9104 - 9109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Gao, B. E. Willcox, J. R. Wyer, J. M. Boulter, C. A. O'Callaghan, K. Maenaka, D. I. Stuart, E. Y. Jones, P. A. Van Der Merwe, J. I. Bell, et al. Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8alpha alpha J. Biol. Chem., May 12, 2000; 275(20): 15232 - 15238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Avril, A.-C. Jarousseau, H. Watier, J. Boucraut, P. Le Bouteiller, P. Bardos, and G. Thibault Trophoblast Cell Line Resistance to NK Lysis Mainly Involves an HLA Class I-Independent Mechanism J. Immunol., May 15, 1999; 162(10): 5902 - 5909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Mandelboim, L. Pazmany, D. M. Davis, M. Vales-Gomez, H. T. Reyburn, B. Rybalov, and J. L. Strominger Multiple receptors for HLA-G on human natural killer cells PNAS, December 23, 1997; 94(26): 14666 - 14670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Rouas-Freiss, R. M.-B. Goncalves, C. Menier, J. Dausset, and E. D. Carosella Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis PNAS, October 14, 1997; 94(21): 11520 - 11525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Crisa, M. T. McMaster, J. K. Ishii, S. J. Fisher, and D. R. Salomon Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts J. Exp. Med., July 21, 1997; 186(2): 289 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Yokoyama The mother-child union: The case of missing-self and protection of the fetus PNAS, June 10, 1997; 94(12): 5998 - 6000. [Full Text] [PDF]
|
|
|
|
|
|
N. Rouas-Freiss, R. E. Marchal, M. Kirszenbaum, J. Dausset, and E. D. Carosella The alpha 1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? PNAS, May 13, 1997; 94(10): 5249 - 5254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Munz, N. Holmes, A. King, Y. W. Loke, M. Colonna, H. Schild, and H.-G. Rammensee Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells J. Exp. Med., February 3, 1997; 185(3): 385 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pazmany, O. Mandelboim, M. Valés-Gómez, D. M. Davis, H. T. Reyburn, and J. L. Strominger Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells Science, November 1, 1996; 274(5288): 792 - 795. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cross, Z Werb, and S. Fisher Implantation and the placenta: key pieces of the development puzzle Science, December 2, 1994; 266(5190): 1508 - 1518. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
